Complement system in cancer: friend or foe of immunotherapy

Journal for ImmunoTherapy of Cancer | |

<p>The complement system, a key component of the immune response, plays a dual role in cancer, influencing both tumor suppression and progression. Its three activation pathways (classical, alternative, and lectin) initiate immune processes, including opsonization and cell lysis. Within the tumor microenvironment, however, complement activation can paradoxically support immune-mediated tumor control or contribute to immune evasion and tumor growth. Therapeutic…

Topics: blood-cancer, cervical-cancer, immunotherapy, new-technology, research